To investigate whether the tumors carrying mutations in both FGFR2 and KRAS were polyclonal, DNA from a different portion of the tumor was extracted from archived paraffin tissue and in all four cases both mutations were confirmed. This evidence concerns the gene FGFR2 and neoplasm.